Combination Of Vaccination And Ox40 Agonists

Patent No. EP3116535 (titled "Combination Of Vaccination And Ox40 Agonists") was filed by Curevac on Mar 12, 2014. The application was issued on Aug 7, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIONTECH RNA PHARMACEUTICALSMay 7, 2020THOMANN
BIONTECHMay 7, 2020THOMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3116535

CUREVAC
Application Number
EP14716752A
Filing Date
Mar 12, 2014
Status
Revoked
Sep 2, 2024
Publication Date
Aug 7, 2019